Keyphrases
Citalopram
100%
Cytochrome P450 2D6 (CYP2D6)
100%
Dose Effect
100%
CYP2C19
100%
Paroxetine
100%
Fluoxetine
100%
Cytochrome P450 1A2 (CYP1A2)
100%
Fluvoxamine
100%
Selective Serotonin Reuptake Inhibitors
44%
Mephenytoin
44%
Poor Metabolizer
33%
Extensive Metabolizer
33%
Caffeine
33%
Sparteine
33%
Increased Dose
22%
Potent Inhibitor
22%
Metabolic Ratio
22%
Testing Trends
22%
Page Test
22%
Multiple Dose
11%
Steady State
11%
Pharmacokinetic Study
11%
Urinary Excretion
11%
Healthy Young
11%
Demethylation
11%
Limit of Quantification
11%
Clinical Prediction Model
11%
Single Oral Dose
11%
Single-dose Studies
11%
Long Half-life
11%
R-ratio
11%
Norfluoxetine
11%
Pharmacology, Toxicology and Pharmaceutical Science
CYP2D6
100%
CYP2C19
100%
Paroxetine
100%
Citalopram
100%
Fluoxetine
100%
CYP1A2
100%
Fluvoxamine
100%
Selective Serotonin Reuptake Inhibitor
44%
Mephenytoin
44%
Sparteine
33%
Pharmacokinetics
11%
Seproxetine
11%